Sarcosine as a potential prostate cancer biomarker and therapeutic target. 2010

Caitlin E Baum, and Douglas K Price, and William D Figg
Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.

UI MeSH Term Description Entries
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012521 Sarcosine An amino acid intermediate in the metabolism of choline. Methylglycine,Magnesium Sarcosylate,N-Methylglycine,Sarcosine Hydrochloride,Sarcosine Monosodium Salt,Sodium Sarcosinate,N Methylglycine,Sarcosinate, Sodium,Sarcosylate, Magnesium
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers

Related Publications

Caitlin E Baum, and Douglas K Price, and William D Figg
July 2013, International journal of molecular sciences,
Caitlin E Baum, and Douglas K Price, and William D Figg
February 2010, The Prostate,
Caitlin E Baum, and Douglas K Price, and William D Figg
August 2020, Biomolecules,
Caitlin E Baum, and Douglas K Price, and William D Figg
December 2011, Journal of separation science,
Caitlin E Baum, and Douglas K Price, and William D Figg
March 2015, Oncotarget,
Caitlin E Baum, and Douglas K Price, and William D Figg
January 2017, Current pharmaceutical design,
Caitlin E Baum, and Douglas K Price, and William D Figg
January 2021, American journal of translational research,
Caitlin E Baum, and Douglas K Price, and William D Figg
December 2011, Biochimica et biophysica acta,
Caitlin E Baum, and Douglas K Price, and William D Figg
November 2011, Therapeutic advances in medical oncology,
Caitlin E Baum, and Douglas K Price, and William D Figg
December 2013, Targeted oncology,
Copied contents to your clipboard!